Amit K. Srivastava
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Amit K. Srivastava has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Charles S. Cox
Program in Children's Regenerative Medicine, Department of Pediatric Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
5 shared publications- Jeff W. M. Bulte
The Johns Hopkins University School of Medicine
5 shared publications Charles E. Wade
Department of Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX
4 shared publications- Scott D. Olson
Department of Pediatric Surgery, The University of Texas Health Science Center at Houston, Houston, 77030, Texas, USA
4 shared publications - Ernesto Lopez
Center for Translational Injury Research (CeTIR), Department of Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas
3 shared publications Jessica C. Cardenas
Division of GI, Trauma, and Endocrine Surgery, Department of Surgery, University of Colorado Denver School of Medicine, Aurora, CO
3 shared publications
Latest Publications
- Open Access
- 16 February 2026
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3  (2) , 100148
Donor sex and platelet storage change the therapeutic effects of platelet-derived extracellular vesicles on endothelium
- 16 February 2026
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3  (2) , 100148
Open AccessDonor sex and platelet storage change the therapeutic effects of platelet-derived extracellular vesicles on endothelium
- Open Access
- 9 December 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63  (1) , 273
The Breakdown of Neurovascular Barriers: Molecular Mechanisms of Tight Junction Dysfunction
The central nervous system (CNS) relies on tightly regulated barriers to maintain homeostasis and protect neural tissue from blood-borne toxins, pathogens, and inflammatory mediators. Tight junctions (TJs) are critical components of the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB), forming selective paracellular seals that regulate molecular trafficking. These structures comprise transmembrane proteins and cytoplasmic scaffolding proteins, which anchor TJs to the actin cytoskeleton. The spatial organization and function of TJs are dynamically regulated by calcium-dependent signaling, phosphorylation events, and G-protein-mediated pathways, which govern their assembly, disassembly, and response to physiological and pathological stimuli. The integrity of TJ complexes is particularly vulnerable to disruption in neurological disorders. Dysregulation of key TJ proteins has been implicated in neurodegenerative diseases, neuroinflammation, and CNS injury, leading to barrier permeability defects that exacerbate disease progression. Emerging therapeutic strategies aim to modulate TJs to stabilize barrier integrity and to mitigate pathology. This review examines the molecular architecture and regulatory mechanisms of TJ complexes, their dysfunction in disease states, and the translational potential of targeting them for therapy. A detailed understanding of TJ dynamics is essential for developing strategies to restore barrier function in neurological disorders.
- 9 December 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63  (1) , 273
Open AccessThe Breakdown of Neurovascular Barriers: Molecular Mechanisms of Tight Junction Dysfunction
The central nervous system (CNS) relies on tightly regulated barriers to maintain homeostasis and protect neural tissue from blood-borne toxins, pathogens, and inflammatory mediators. Tight junctions (TJs) are critical components of the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB), forming selective paracellular seals that regulate molecular trafficking. These structures comprise transmembrane proteins and cytoplasmic scaffolding proteins, which anchor TJs to the actin cytoskeleton. The spatial organization and function of TJs are dynamically regulated by calcium-dependent signaling, phosphorylation events, and G-protein-mediated pathways, which govern their assembly, disassembly, and response to physiological and pathological stimuli. The integrity of TJ complexes is particularly vulnerable to disruption in neurological disorders. Dysregulation of key TJ proteins has been implicated in neurodegenerative diseases, neuroinflammation, and CNS injury, leading to barrier permeability defects that exacerbate disease progression. Emerging therapeutic strategies aim to modulate TJs to stabilize barrier integrity and to mitigate pathology. This review examines the molecular architecture and regulatory mechanisms of TJ complexes, their dysfunction in disease states, and the translational potential of targeting them for therapy. A detailed understanding of TJ dynamics is essential for developing strategies to restore barrier function in neurological disorders.
- Open Access
Donor Sex and Platelet Storage Influence the Therapeutic Effects of Platelet-Derived Extracellular Vesicles on Endothelial Barrier Function
Platelet-derived extracellular vesicles (PEVs) play an active role in vascular protection and repair and are being explored as a viable alternative to platelet therapy. Because platelet function and stability are shaped by donor sex and storage conditions, these same factors are likely to influence the PEVs they release. Understanding these influences is key to developing PEVs into a safe and dependable therapeutic option. In this study, we investigated how donor sex and platelet storage affect the therapeutic properties of PEVs. To address this, PEVs were isolated from platelets of healthy male and female donors. Platelets were either processed immediately after blood collection to represent a resting state or stored overnight at room temperature on a rocker to mimic platelet storage conditions. PEVs isolated from these preparations displayed similar size, morphology, and cellular uptake across groups, but their biological effects diverged. Female PEVs, particularly from resting platelets, provided the strongest protection against thrombin-induced endothelial barrier disruption, stabilized junctional proteins, and reduced oxidative stress. Male PEVs showed weaker barrier protection compared to female-derived PEVs but more pronounced modulation of certain inflammatory mediators. In addition, PEVs derived from resting platelets (RP-PEVs) consistently showed stronger protective effects than those from stored platelets (SP-PEVs), regardless of donor sex. These results highlight that donor sex and platelet storage influence PEVs function and underscore the need to account for both when developing PEV-based therapies. Key Point: The endothelial-protective effects of platelet-derived extracellular vesicles are modulated by platelet storage conditions and donor sex.
Open AccessDonor Sex and Platelet Storage Influence the Therapeutic Effects of Platelet-Derived Extracellular Vesicles on Endothelial Barrier Function
Platelet-derived extracellular vesicles (PEVs) play an active role in vascular protection and repair and are being explored as a viable alternative to platelet therapy. Because platelet function and stability are shaped by donor sex and storage conditions, these same factors are likely to influence the PEVs they release. Understanding these influences is key to developing PEVs into a safe and dependable therapeutic option. In this study, we investigated how donor sex and platelet storage affect the therapeutic properties of PEVs. To address this, PEVs were isolated from platelets of healthy male and female donors. Platelets were either processed immediately after blood collection to represent a resting state or stored overnight at room temperature on a rocker to mimic platelet storage conditions. PEVs isolated from these preparations displayed similar size, morphology, and cellular uptake across groups, but their biological effects diverged. Female PEVs, particularly from resting platelets, provided the strongest protection against thrombin-induced endothelial barrier disruption, stabilized junctional proteins, and reduced oxidative stress. Male PEVs showed weaker barrier protection compared to female-derived PEVs but more pronounced modulation of certain inflammatory mediators. In addition, PEVs derived from resting platelets (RP-PEVs) consistently showed stronger protective effects than those from stored platelets (SP-PEVs), regardless of donor sex. These results highlight that donor sex and platelet storage influence PEVs function and underscore the need to account for both when developing PEV-based therapies. Key Point: The endothelial-protective effects of platelet-derived extracellular vesicles are modulated by platelet storage conditions and donor sex.
- Open Access
- 18 March 2024
- Published by Wiley in Medicinal Research Reviews
- Vol. 44  (4) , 1923-1966
Most recent advances and applications of extracellular vesicles in tackling neurological challenges
Over the past few decades, there has been a notable increase in the global burden of central nervous system (CNS) diseases. Despite advances in technology and therapeutic options, neurological and neurodegenerative disorders persist as significant challenges in treatment and cure. Recently, there has been a remarkable surge of interest in extracellular vesicles (EVs) as pivotal mediators of intercellular communication. As carriers of molecular cargo, EVs demonstrate the ability to traverse the blood–brain barrier, enabling bidirectional communication. As a result, they have garnered attention as potential biomarkers and therapeutic agents, whether in their natural form or after being engineered for use in the CNS. This review article aims to provide a comprehensive introduction to EVs, encompassing various aspects such as their diverse isolation methods, characterization, handling, storage, and different routes for EV administration. Additionally, it underscores the recent advances in their potential applications in neurodegenerative disorder therapeutics. By exploring their unique capabilities, this study sheds light on the promising future of EVs in clinical research. It considers the inherent challenges and limitations of these emerging applications while incorporating the most recent updates in the field.
- 18 March 2024
- Published by Wiley in Medicinal Research Reviews
- Vol. 44  (4) , 1923-1966
Open AccessMost recent advances and applications of extracellular vesicles in tackling neurological challenges
Over the past few decades, there has been a notable increase in the global burden of central nervous system (CNS) diseases. Despite advances in technology and therapeutic options, neurological and neurodegenerative disorders persist as significant challenges in treatment and cure. Recently, there has been a remarkable surge of interest in extracellular vesicles (EVs) as pivotal mediators of intercellular communication. As carriers of molecular cargo, EVs demonstrate the ability to traverse the blood–brain barrier, enabling bidirectional communication. As a result, they have garnered attention as potential biomarkers and therapeutic agents, whether in their natural form or after being engineered for use in the CNS. This review article aims to provide a comprehensive introduction to EVs, encompassing various aspects such as their diverse isolation methods, characterization, handling, storage, and different routes for EV administration. Additionally, it underscores the recent advances in their potential applications in neurodegenerative disorder therapeutics. By exploring their unique capabilities, this study sheds light on the promising future of EVs in clinical research. It considers the inherent challenges and limitations of these emerging applications while incorporating the most recent updates in the field.
- Open Access
- 18 July 2022
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 980763
Editorial: Glia-Mediated Neurotoxicity: Uncovering the Molecular Mechanisms
Editorial: Glia-Mediated Neurotoxicity: Uncovering the Molecular Mechanisms
- 18 July 2022
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 980763
Open AccessEditorial: Glia-Mediated Neurotoxicity: Uncovering the Molecular Mechanisms
Editorial: Glia-Mediated Neurotoxicity: Uncovering the Molecular Mechanisms
- Open Access
- 13 April 2022
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 844194
Role of Extracellular Vesicles in Glia-Neuron Intercellular Communication
Cross talk between glia and neurons is crucial for a variety of biological functions, ranging from nervous system development, axonal conduction, synaptic transmission, neural circuit maturation, to homeostasis maintenance. Extracellular vesicles (EVs), which were initially described as cellular debris and were devoid of biological function, are now recognized as key components in cell-cell communication and play a critical role in glia-neuron communication. EVs transport the proteins, lipids, and nucleic acid cargo in intercellular communication, which alters target cells structurally and functionally. A better understanding of the roles of EVs in glia-neuron communication, both in physiological and pathological conditions, can aid in the discovery of novel therapeutic targets and the development of new biomarkers. This review aims to demonstrate that different types of glia and neuronal cells secrete various types of EVs, resulting in specific functions in intercellular communications.
- 13 April 2022
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 844194
Open AccessRole of Extracellular Vesicles in Glia-Neuron Intercellular Communication
Cross talk between glia and neurons is crucial for a variety of biological functions, ranging from nervous system development, axonal conduction, synaptic transmission, neural circuit maturation, to homeostasis maintenance. Extracellular vesicles (EVs), which were initially described as cellular debris and were devoid of biological function, are now recognized as key components in cell-cell communication and play a critical role in glia-neuron communication. EVs transport the proteins, lipids, and nucleic acid cargo in intercellular communication, which alters target cells structurally and functionally. A better understanding of the roles of EVs in glia-neuron communication, both in physiological and pathological conditions, can aid in the discovery of novel therapeutic targets and the development of new biomarkers. This review aims to demonstrate that different types of glia and neuronal cells secrete various types of EVs, resulting in specific functions in intercellular communications.
- Open Access
- 27 November 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9  (1) , 1-10
Platelet-derived- Extracellular Vesicles Promote Hemostasis and Prevent the Development of Hemorrhagic Shock
Every year more than 500,000 deaths are attributed to trauma worldwide and severe hemorrhage is present in most of them. Transfused platelets have been shown to improve survival in trauma patients, although its mechanism is only partially known. Platelet derived-extracellular vesicles (PEVs) are small vesicles released from platelets upon activation and/or mechanical stimulation and many of the benefits attributed to platelets could be mediated through PEVs. Based on the available literature, we hypothesized that transfusion of human PEVs would promote hemostasis, reduce blood loss and attenuate the progression to hemorrhagic shock following severe trauma. In this study, platelet units from four different donors were centrifuged to separate platelets and PEVs. The pellets were washed to obtain plasma-free platelets to use in the rodent model. The supernatant was subjected to tangential flow filtration for isolation and purification of PEVs. PEVs were assessed by total count and particle size distribution by Nanoparticle Tracking Analysis (NTA) and characterized for cells of origin and expression of EV specific-surface and cytosolic markers by flow cytometry. The coagulation profile from PEVs was assessed by calibrated automated thrombography (CAT) and thromboelastography (TEG). A rat model of uncontrolled hemorrhage was used to compare the therapeutic effects of 8.7 × 108 fresh platelets (FPLT group, n = 8), 7.8 × 109 PEVs (PEV group, n = 8) or Vehicle (Control, n = 16) following severe trauma. The obtained pool of PEVs from 4 donors had a mean size of 101 ± 47 nm and expressed the platelet-specific surface marker CD41 and the EV specific markers CD9, CD61, CD63, CD81 and HSP90. All PEV isolates demonstrated a dose-dependent increase in the rate and amount of thrombin generated and overall clot strength. In vivo experiments demonstrated a 24% reduction in abdominal blood loss following liver trauma in the PEVs group when compared with the control group (9.9 ± 0.4 vs. 7.5 ± 0.5 mL, p < 0.001>). The PEV group also exhibited improved outcomes in blood pressure, lactate level, base excess and plasma protein concentration compared to the Control group. Fresh platelets failed to improve these endpoints when compared to Controls. Altogether, these results indicate that human PEVs provide pro-hemostatic support following uncontrolled bleeding. As an additional therapeutic effect, PEVs improve the outcome following severe trauma by maintaining hemodynamic stability and attenuating the development of ischemia, base deficit, and cardiovascular shock.
- 27 November 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9  (1) , 1-10
Open AccessPlatelet-derived- Extracellular Vesicles Promote Hemostasis and Prevent the Development of Hemorrhagic Shock
Every year more than 500,000 deaths are attributed to trauma worldwide and severe hemorrhage is present in most of them. Transfused platelets have been shown to improve survival in trauma patients, although its mechanism is only partially known. Platelet derived-extracellular vesicles (PEVs) are small vesicles released from platelets upon activation and/or mechanical stimulation and many of the benefits attributed to platelets could be mediated through PEVs. Based on the available literature, we hypothesized that transfusion of human PEVs would promote hemostasis, reduce blood loss and attenuate the progression to hemorrhagic shock following severe trauma. In this study, platelet units from four different donors were centrifuged to separate platelets and PEVs. The pellets were washed to obtain plasma-free platelets to use in the rodent model. The supernatant was subjected to tangential flow filtration for isolation and purification of PEVs. PEVs were assessed by total count and particle size distribution by Nanoparticle Tracking Analysis (NTA) and characterized for cells of origin and expression of EV specific-surface and cytosolic markers by flow cytometry. The coagulation profile from PEVs was assessed by calibrated automated thrombography (CAT) and thromboelastography (TEG). A rat model of uncontrolled hemorrhage was used to compare the therapeutic effects of 8.7 × 108 fresh platelets (FPLT group, n = 8), 7.8 × 109 PEVs (PEV group, n = 8) or Vehicle (Control, n = 16) following severe trauma. The obtained pool of PEVs from 4 donors had a mean size of 101 ± 47 nm and expressed the platelet-specific surface marker CD41 and the EV specific markers CD9, CD61, CD63, CD81 and HSP90. All PEV isolates demonstrated a dose-dependent increase in the rate and amount of thrombin generated and overall clot strength. In vivo experiments demonstrated a 24% reduction in abdominal blood loss following liver trauma in the PEVs group when compared with the control group (9.9 ± 0.4 vs. 7.5 ± 0.5 mL, p < 0.001>). The PEV group also exhibited improved outcomes in blood pressure, lactate level, base excess and plasma protein concentration compared to the Control group. Fresh platelets failed to improve these endpoints when compared to Controls. Altogether, these results indicate that human PEVs provide pro-hemostatic support following uncontrolled bleeding. As an additional therapeutic effect, PEVs improve the outcome following severe trauma by maintaining hemodynamic stability and attenuating the development of ischemia, base deficit, and cardiovascular shock.
- 1 June 2019
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 86  (6) , 931-942
Regulation of endothelial cell permeability by platelet-derived extracellular vesicles
BACKGROUND: Platelet (Plt)-derived extracellular vesicles (Plt-EVs) have hemostatic properties similar to Plts. In addition to hemostasis, Plts also function to stabilize the vasculature and maintain endothelial cell (EC) barrier integrity. We hypothesized that Plt-EVs would inhibit vascular EC permeability, similar to fresh Plts. To investigate this hypothesis, we used in vitro and in vivo models of vascular endothelial compromise and bleeding.METHODS: In the vitro model, Plt-EVs were isolated by ultracentrifugation and characterized for Plt markers and particle size distribution. Effects of Plts and Plt-EVs on endothelial barrier function were assessed by transendothelial electrical resistance measurements and histological analysis of endothelial junction proteins. Hemostatic potential of Plt-EVs and Plts was assessed by multiple electrode Plt aggregometry. Using an in vivo model, the effects of Plts and Plt-EVs on vascular permeability and bleeding were assessed in non-obese diabetic-severe combined immunodeficient (NOD-SCID) mice by an established Miles assay of vascular permeability and a tail snip bleeding assay.RESULTS: In the in vitro model, Plt-EVs displayed exosomal size distribution and expressed Plt-specific surface markers. Platelets and Plt-EVs decreased EC permeability and restored EC junctions after thrombin challenge. Multiplate aggregometry revealed that Plt-EVs enhanced thrombin receptor–activating peptide-mediated aggregation of whole blood, whereas Plts enhanced thrombin receptor–activating peptide–, arachidonic acid–, collagen-, and adenosine diphosphate–mediated aggregation. In the in vivo model, Plt-EVs are equivalent to Plts in attenuating vascular endothelial growth factor (VEGF)-A–induced vascular permeability and uncontrolled blood loss in a tail snip hemorrhage model.CONCLUSION: Our study is the first to report that Plt-EVs might provide a feasible product for transfusion in trauma patients to attenuate bleeding, inhibit vascular permeability, and mitigate the endotheliopathy of trauma.
- 1 June 2019
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 86  (6) , 931-942
Regulation of endothelial cell permeability by platelet-derived extracellular vesicles
BACKGROUND: Platelet (Plt)-derived extracellular vesicles (Plt-EVs) have hemostatic properties similar to Plts. In addition to hemostasis, Plts also function to stabilize the vasculature and maintain endothelial cell (EC) barrier integrity. We hypothesized that Plt-EVs would inhibit vascular EC permeability, similar to fresh Plts. To investigate this hypothesis, we used in vitro and in vivo models of vascular endothelial compromise and bleeding.METHODS: In the vitro model, Plt-EVs were isolated by ultracentrifugation and characterized for Plt markers and particle size distribution. Effects of Plts and Plt-EVs on endothelial barrier function were assessed by transendothelial electrical resistance measurements and histological analysis of endothelial junction proteins. Hemostatic potential of Plt-EVs and Plts was assessed by multiple electrode Plt aggregometry. Using an in vivo model, the effects of Plts and Plt-EVs on vascular permeability and bleeding were assessed in non-obese diabetic-severe combined immunodeficient (NOD-SCID) mice by an established Miles assay of vascular permeability and a tail snip bleeding assay.RESULTS: In the in vitro model, Plt-EVs displayed exosomal size distribution and expressed Plt-specific surface markers. Platelets and Plt-EVs decreased EC permeability and restored EC junctions after thrombin challenge. Multiplate aggregometry revealed that Plt-EVs enhanced thrombin receptor–activating peptide-mediated aggregation of whole blood, whereas Plts enhanced thrombin receptor–activating peptide–, arachidonic acid–, collagen-, and adenosine diphosphate–mediated aggregation. In the in vivo model, Plt-EVs are equivalent to Plts in attenuating vascular endothelial growth factor (VEGF)-A–induced vascular permeability and uncontrolled blood loss in a tail snip hemorrhage model.CONCLUSION: Our study is the first to report that Plt-EVs might provide a feasible product for transfusion in trauma patients to attenuate bleeding, inhibit vascular permeability, and mitigate the endotheliopathy of trauma.
- Open Access
- 1 April 2019
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 14  (4) , 295-307
Human Umbilical Cord Blood Cells Restore Vascular Integrity in Injured Rat Brain and Modulate Inflammation in Vitro
Aim: Traumatic brain injury is a complex condition consisting of a mechanical injury with neurovascular disruption and inflammation with limited clinical interventions available. A growing number o... Representative coronal sections from experimental groups injured with a sham injury (top left), a controlled cortical impact (top right), or a controlled cortical impact and an infusion with human ...
- 1 April 2019
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 14  (4) , 295-307
Open AccessHuman Umbilical Cord Blood Cells Restore Vascular Integrity in Injured Rat Brain and Modulate Inflammation in Vitro
Aim: Traumatic brain injury is a complex condition consisting of a mechanical injury with neurovascular disruption and inflammation with limited clinical interventions available. A growing number o... Representative coronal sections from experimental groups injured with a sham injury (top left), a controlled cortical impact (top right), or a controlled cortical impact and an infusion with human ...
- 14 September 2018
- Published by Elsevier
Current Approaches to Tissue Engineering of the Nervous System
- 14 September 2018
- Published by Elsevier
Current Approaches to Tissue Engineering of the Nervous System